154 related articles for article (PubMed ID: 18068811)
21. Interferon-beta regulates cytokines and BDNF: greater effect in relapsing than in progressive multiple sclerosis.
Hamamcioglu K; Reder AT
Mult Scler; 2007 May; 13(4):459-70. PubMed ID: 17463069
[TBL] [Abstract][Full Text] [Related]
22. IFNbeta-1a therapy for multiple sclerosis expands regulatory CD8+ T cells and decreases memory CD8+ subset: a longitudinal 1-year study.
Aristimuño C; de Andrés C; Bartolomé M; de las Heras V; Martínez-Ginés ML; Arroyo R; Fernández-Cruz E; Sánchez-Ramón S
Clin Immunol; 2010 Feb; 134(2):148-57. PubMed ID: 19900844
[TBL] [Abstract][Full Text] [Related]
23. Lymphocyte calcium influx kinetics in multiple sclerosis treated without or with interferon β.
Toldi G; Folyovich A; Simon Z; Zsiga K; Kaposi A; Mészáros G; Tulassay T; Vásárhelyi B
J Neuroimmunol; 2011 Aug; 237(1-2):80-6. PubMed ID: 21764463
[TBL] [Abstract][Full Text] [Related]
24. Altered naive CD4 and CD8 T cell homeostasis in patients with relapsing-remitting multiple sclerosis: thymic versus peripheral (non-thymic) mechanisms.
Duszczyszyn DA; Beck JD; Antel J; Bar-Or A; Lapierre Y; Gadag V; Haegert DG
Clin Exp Immunol; 2006 Feb; 143(2):305-13. PubMed ID: 16412055
[TBL] [Abstract][Full Text] [Related]
25. IFN-β induces the proliferation of CD4+CD25+Foxp3+ regulatory T cells through upregulation of GITRL on dendritic cells in the treatment of multiple sclerosis.
Chen M; Chen G; Deng S; Liu X; Hutton GJ; Hong J
J Neuroimmunol; 2012 Jan; 242(1-2):39-46. PubMed ID: 22112394
[TBL] [Abstract][Full Text] [Related]
26. The clinical effect of neutralizing antibodies against interferon-beta is independent of the type of interferon-beta used for patients with relapsing-remitting multiple sclerosis.
Koch-Henriksen N; Sorensen PS; Bendtzen K; Flachs EM
Mult Scler; 2009 May; 15(5):601-5. PubMed ID: 19299439
[TBL] [Abstract][Full Text] [Related]
27. Increase of CD8+ T-effector memory cells in peripheral blood of patients with relapsing-remitting multiple sclerosis compared to healthy controls.
Haegele KF; Stueckle CA; Malin JP; Sindern E
J Neuroimmunol; 2007 Feb; 183(1-2):168-74. PubMed ID: 17084910
[TBL] [Abstract][Full Text] [Related]
28. Treatment with type I interferons induces a regulatory T cell subset in peripheral blood mononuclear cells from multiple sclerosis patients.
Pentón-Rol G; Cervantes-Llanos M; Cabrera-Gómez JA; Alonso-Ramírez R; Valenzuela-Silva C; Rodríguez-Lara R; Montero-Casimiro E; Bello-Rivero I; López-Saura P
Int Immunopharmacol; 2008 Jun; 8(6):881-6. PubMed ID: 18442793
[TBL] [Abstract][Full Text] [Related]
29. Association between peripheral IFN-gamma producing CD8+ T-cells and disability score in relapsing-remitting multiple sclerosis.
Sepulcre J; Sanchez-Ibarrola A; Moreno C; de Castro P
Cytokine; 2005 Oct; 32(2):111-6. PubMed ID: 16246570
[TBL] [Abstract][Full Text] [Related]
30. Opposite effects of interferon-β on new B and T cell release from production sites in multiple sclerosis patients.
Zanotti C; Chiarini M; Serana F; Capra R; Rottoli M; Rovaris M; Cavaletti G; Clerici R; Rezzonico M; Caimi L; Imberti L
J Neuroimmunol; 2011 Dec; 240-241():147-50. PubMed ID: 22078237
[TBL] [Abstract][Full Text] [Related]
31. Thymectomy in early childhood: significant alterations of the CD4(+)CD45RA(+)CD62L(+) T cell compartment in later life.
Prelog M; Keller M; Geiger R; Brandstätter A; Würzner R; Schweigmann U; Zlamy M; Zimmerhackl LB; Grubeck-Loebenstein B
Clin Immunol; 2009 Feb; 130(2):123-32. PubMed ID: 18977182
[TBL] [Abstract][Full Text] [Related]
32. Migration of T-cell subsets in multiple sclerosis and the effect of interferon-beta1a.
Dressel A; Mirowska-Guzel D; Gerlach C; Weber F
Acta Neurol Scand; 2007 Sep; 116(3):164-8. PubMed ID: 17714329
[TBL] [Abstract][Full Text] [Related]
33. An imbalance of two functionally and phenotypically different subsets of plasmacytoid dendritic cells characterizes the dysfunctional immune regulation in multiple sclerosis.
Schwab N; Zozulya AL; Kieseier BC; Toyka KV; Wiendl H
J Immunol; 2010 May; 184(9):5368-74. PubMed ID: 20357264
[TBL] [Abstract][Full Text] [Related]
34. Differential reconstitution of T cell subsets following immunodepleting treatment with alemtuzumab (anti-CD52 monoclonal antibody) in patients with relapsing-remitting multiple sclerosis.
Zhang X; Tao Y; Chopra M; Ahn M; Marcus KL; Choudhary N; Zhu H; Markovic-Plese S
J Immunol; 2013 Dec; 191(12):5867-74. PubMed ID: 24198283
[TBL] [Abstract][Full Text] [Related]
35. Interferon beta inhibits the Th17 cell-mediated autoimmune response in patients with relapsing-remitting multiple sclerosis.
Zhang X; Markovic-Plese S
Clin Neurol Neurosurg; 2010 Sep; 112(7):641-5. PubMed ID: 20570038
[TBL] [Abstract][Full Text] [Related]
36. CD127 immunophenotyping suggests altered CD4+ T cell regulation in primary progressive multiple sclerosis.
McKay FC; Swain LI; Schibeci SD; Rubio JP; Kilpatrick TJ; Heard RN; Stewart GJ; Booth DR
J Autoimmun; 2008 Aug; 31(1):52-8. PubMed ID: 18406576
[TBL] [Abstract][Full Text] [Related]
37. [Changes in lymphocyte subsets s and treatment with beta interferon in active multiple sclerosis].
Gata JM; García-Moreno JM; Dinca L; Sánchez-Margalet V; Navarro G; Izquierdo G
Rev Neurol; 1998 Dec; 27(160):939-42. PubMed ID: 9951008
[TBL] [Abstract][Full Text] [Related]
38. Identification of non-naïve CD4+CD45RA+ T cell subsets in adult allogeneic haematopoietic cell transplant recipients.
Fallen PR; Duarte RF; McGreavey L; Potter M; Ethell M; Prentice HG; Madrigal JA; Travers PJ
Bone Marrow Transplant; 2003 Sep; 32(6):609-16. PubMed ID: 12953134
[TBL] [Abstract][Full Text] [Related]
39. Modulation of the central memory and Tr1-like regulatory T cells in multiple sclerosis patients responsive to interferon-beta therapy.
Chiarini M; Serana F; Zanotti C; Capra R; Rasia S; Rottoli M; Rovaris M; Caputo D; Cavaletti G; Frigo M; Frigeni B; Clerici R; Rezzonico M; Caimi L; Imberti L
Mult Scler; 2012 Jun; 18(6):788-98. PubMed ID: 22086901
[TBL] [Abstract][Full Text] [Related]
40. Reduced thymic output and peripheral naïve CD4 T-cell alterations in primary progressive multiple sclerosis (PPMS).
Haegert DG; Hackenbroch JD; Duszczyszyn D; Fitz-Gerald L; Zastepa E; Mason H; Lapierre Y; Antel J; Bar-Or A
J Neuroimmunol; 2011 Apr; 233(1-2):233-9. PubMed ID: 21272945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
